Back to RhumbLine Advisers RhumbLine Advisers

QNCX

17 quarters

Position history for RhumbLine AdvisersRhumbLine Advisers's holdings in QUINCE THERAPEUTICS INC

No. RhumbLine Advisers exited its QNCX (Quince Therapeutics) position in Q3 2024. Its Q2 2024 13F listed 394 shares worth $295. RhumbLine Advisers first reported QNCX in Q4 2019 and held it in 15 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$622,000

Total Shares Change

-11,071

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q3
Latest
Exited
0
-100.0%
$00.0%$155.20
0
2024-Q2
Unchanged
394
0.0%
$2950.0%$150.00
0
2024-Q1
Unchanged
394
0.0%
$4170.0%$212.00
0
2023-Q4
Unchanged
394
0.0%
$4130.0%$210.00
0
2023-Q3
Unchanged
394
0.0%
$4410.0%$224.00
0
2023-Q2
New
394
-
$5920.0%$301.00
17
2022-Q2
Exited
0
-100.0%
$00.0%$444.00
0
2022-Q1
Increased
19,411
+1.2%
$120,0000.0%$1,238.00
22
2021-Q4
Decreased
19,173
-3.1%
$242,0000.0%$2,524.00
0
2021-Q3
Increased
19,793
+4.3%
$1.8M0.0%$18,332.00
27
2021-Q2
Increased
18,971
+3.9%
$1M0.0%$10,600.00
26
2021-Q1
Decreased
18,254
-5.7%
$658,0000.0%$7,206.00
0
2020-Q4
Increased
19,351
+6.1%
$538,0000.0%$5,556.00
26
2020-Q3
Decreased
18,239
-11.6%
$912,0000.0%$10,000.00
0
2020-Q2
Increased
20,639
+51.3%
$956,0000.0%$9,260.00
35
2020-Q1
Increased
13,641
+23.2%
$622,0000.0%$9,122.00
30
2019-Q4
New
11,071
-
$622,0000.0%$11,228.00
34

Other major holders of QNCX: Capital World Investors, Capital International Investors, Capital Research Global Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used